FUJIFILM Diosynth Biotechnologies has completed its new facility in Darlington, United Kingdom, which is now operational and can carry out current good manufacturing practice (CGMP) manufacturing of viral vector-based gene therapies, oncolytic viruses, and viral vaccines for clinical trials. The facility holds a cell culture capacity of up to 200L. Source: Biopharm International 21/9/2023